FIDELITY ADVISOR Mutual Fund Forward View - Price Action Indicator
| FBTIX Fund | USD 39.95 -0.70 -1.72% |
The Price Action Indicator forecast shown here for FIDELITY ADVISOR is reference data produced from its historical price series. The projected value and error measures below serve as reference information. This data is provided for reference and analytical review. The Price Action Indicator output serves as one input among many for analytical review.
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997. This Price Action Indicator reference page for FIDELITY ADVISOR presents model-generated projections from historical price data for informational purposes. Price Action Indicator Analysis Today
Fidelity Advisor Biotechnology has current Price Action Indicator of -0.35. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.| Volatility | Backtest | Information Ratio |
FIDELITY ADVISOR Trading Date Momentum
| On March 23 2026 Fidelity Advisor Biotechnology was traded for 39.95 at the closing time. The highest daily price throughout the period was 39.95 and the lowest price was 39.95 . There was no trading activity during the period. Lack of trading volume on 03/23/2026 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare FIDELITY ADVISOR to competition |
Other Forecasting Options for FIDELITY ADVISOR
The distribution of FIDELITY ADVISOR's daily returns is typically non-normal, with fatter tails than a Gaussian model predicts. This can reveal hidden support and resistance zones in FIDELITY ADVISOR's chart that simple price charts miss. The slope of FIDELITY ADVISOR's linear regression channel quantifies trend direction and strength over a chosen lookback period. Divergences between OBV and price can foreshadow trend changes in FIDELITY.FIDELITY ADVISOR Related Equities
Sizing up FIDELITY ADVISOR against these stocks within the Health space shows how it compares on key financial measures. Profit comparisons show whether FIDELITY ADVISOR earns above or below average returns next to its peers.
| Risk & Return | Correlation |
FIDELITY ADVISOR Market Strength Events
Market strength indicators for FIDELITY ADVISOR give insight into the mutual fund's responsiveness to broader forces. These indicators are useful for traders seeking optimal timing for positions in Fidelity Advisor Biotechnology. Market strength analysis for Fidelity Advisor Biotechnology works best when combined with volume and volatility data. For FIDELITY ADVISOR, strength indicators are a practical complement to price and fundamental analysis.
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 39.95 | |||
| Day Typical Price | 39.95 | |||
| Price Action Indicator | -0.35 | |||
| Period Momentum Indicator | -0.70 | |||
| Relative Strength Index | 41.52 |
FIDELITY ADVISOR Risk Indicators
A thorough review of FIDELITY ADVISOR's risk indicators is an important first step in forecasting its price. Quantifying the risk involved in FIDELITY ADVISOR's allows investors to make better decisions about entry, sizing, and hedging. The assessment of FIDELITY ADVISOR's risk indicators plays a key role in managing investment exposure. Identifying the magnitude of risk in FIDELITY ADVISOR's provides context to choose between accepting or hedging exposure.
| Mean Deviation | 1.16 | |||
| Standard Deviation | 1.44 | |||
| Variance | 2.07 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for FIDELITY ADVISOR
Story coverage around Fidelity Advisor Biotechnology often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.